Figure S1
Dose-response curves for the indicated cell line in the presence of increasing concentrations of cruentaren A.
Hall et. al. Figure S1 Hall et. al. Figure S2 Figure S2 Co-immunoprecipitation of Hsp90α with F 1 F 0 ATP synthase from untreated MCF7 cell lysate with and without F 1 F 0 ATP synthase-specific antibody.
Hall et. al. Figure S3 Figure S3 Western blot for the Hsp90 co-chaperones Hsp70, Cdc37 and p23 following co-immunoprecipitation using an anti-Hsp90α antibody (Assay Designs) from MCF7 cell lysates treated for 24 and 48 hours with 50 nM cruentaren A.
Hall et. al. Figure S4 Figure S4 Immunofluorescence images of the nucleus (DAPI), F 1 F 0 ATP synthase, Raf-1, and the merged images of untreated MCF7 cells.
Figure S5
Immunofluorescence images of the nucleus (DAPI), Hsp90β, and the merged images of untreated MCF7 cells after 48 hours of incubation with either vehicle (0.1% DMSO) or 50 nM cruentaren A.
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